Prosecution Insights
Last updated: May 29, 2026
Application No. 18/608,580

LASER TREATMENT SAFETY SYSTEM

Non-Final OA §103§DP
Filed
Mar 18, 2024
Priority
May 17, 2022 — CIP of 12/137,997 +2 more
Examiner
LUKJAN, SEBASTIAN X
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Bellamia Technologies Inc.
OA Round
3 (Non-Final)
76%
Grant Probability
Favorable
3-4
OA Rounds
10m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 76% — above average
76%
Career Allowance Rate
388 granted / 509 resolved
+6.2% vs TC avg
Strong +42% interview lift
Without
With
+41.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
30 currently pending
Career history
550
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
86.6%
+46.6% vs TC avg
§102
2.5%
-37.5% vs TC avg
§112
6.9%
-33.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 509 resolved cases

Office Action

§103 §DP
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment This office action is in response to the amendment filed on 3/30/2026. Currently claims 19-36 are pending. Response to Arguments Applicant’s arguments, see pg. 6, filed 3/30/2026, with respect to the previous rejection of claims 19-36 rejection under 35 USC 112(b) have been fully considered and are persuasive. The previous rejection of claims 19-36 under 35 USC 112(b) has been withdrawn. Applicant’s arguments, see pgs. 7-8, filed 3/30/2026, with respect to the previous rejections of: Claims 19 and 28 under 35 USC 103 as being unpatentable over Knowlton in view of Cannon Claims 20-21 and 29-30 under 35 USC 103 as being unpatentable over Knowlton in view of Cannon in view of Hendrick Claims 22, 24-25, 31 and 33-34 under 35 USC 103 as being unpatentable over Kowlton in view of Cannon in view of Croll Claims 23 and 32 rejected under 35 USC 103 as being unpatentable over Knowlton in view of cannon in view of Croll in view of Daly Claims 26-27 and 35-36 under 35 USC 103 as being unpatentable over Knowlton in view of Cannon in view of Zemmouri have been fully considered and are persuasive. The previous prior art rejection of claims 19-36 has been withdrawn. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 19-36 rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-17 of U.S. Patent No. 11931102 hereafter known as Pat ‘102. Although the claims at issue are not identical, they are not patentably distinct from each other because Pat ‘102 anticipates all the limitations as outlined in the table below. Claim in this application Where claim limitations are found in Pat ‘102 Claim 19 Claim 1 Claim 20 Claim 2 Claim 21 Claim 3 Claim 22 Claim 1 and 4 Claim 23 Claim 4 Claim 24 Claim 5 Claim 25 Claim 6 Claim 26 Claim 7 Claim 27 Claim 8 Claim 28 Claim 9 Claim 29 Claim 10 Claim 30 Claim 11 Claim 31 Claim 12 Claim 32 Claims 9 and 13 Claim 33 Claim 14 Claim 34 Claim 15 Claim 35 Claim 16 Claim 36 Claim 17 Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SEBASTIAN X LUKJAN whose telephone number is (571)270-7305. The examiner can normally be reached Monday - Friday 9:30AM-6PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, NIKETA PATEL can be reached at 571-272-4156. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. SEBASTIAN X LUKJAN /SXL/Examiner, Art Unit 3792 /NIKETA PATEL/Supervisory Patent Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Mar 18, 2024
Application Filed
Mar 05, 2025
Non-Final Rejection mailed — §103, §DP
Jun 05, 2025
Response Filed
Sep 30, 2025
Final Rejection mailed — §103, §DP
Mar 30, 2026
Request for Continued Examination
Apr 18, 2026
Response after Non-Final Action
May 22, 2026
Non-Final Rejection mailed — §103, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12616849
SUNGLASS LENS AND SUNGLASS OPTICS FOR OCULAR PHOTO-BIO-STIMULATION
1y 5m to grant Granted May 05, 2026
Patent 12599779
APPARATUSES FOR TREATING AND/OR DIAGNOSING MOTOR-RELATED NEUROLOGICAL CONDITIONS
12y 4m to grant Granted Apr 14, 2026
Patent 12599780
LASER THERAPY DEVICE FOR THERAPY OF A LIVING TISSUE
2y 8m to grant Granted Apr 14, 2026
Patent 12569141
SYSTEMS AND METHODS FOR LASER CATHETER TREATMENT IN A VESSEL LUMEN
3y 3m to grant Granted Mar 10, 2026
Patent 12558562
BATTERY POWERED SYSTEMS FOR LIGHT THERAPY AND RELATED METHODS
2y 11m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
76%
Grant Probability
99%
With Interview (+41.5%)
3y 0m (~10m remaining)
Median Time to Grant
High
PTA Risk
Based on 509 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month